Catalio Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001958125

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2025 · 45 positions · Total reported value $565.79M · Top-10 concentration 51.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 63.5% · 13 new · 14 cut · 6 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2025 13F filing, Catalio Capital Management, LP disclosed 45 equity positions with a combined reported value of $565.79M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 51.2% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were GILD ($35.51M), BMY ($34.95M), BSX ($34.37M). By sector, the heaviest allocations are Health Care 94.1%, Other 5.9%. Versus the prior quarter, allocation shifted toward Health Care (+5.1pp) and away from Other (-5.1pp).

Versus the prior quarter, Catalio Capital Management, LP opened 13 new positions, trimmed 14 and fully exited 6, a turnover rate of 63.5% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q4 2025 were GILD ($35.51M), BMY ($34.95M), JNJ ($25.01M).

Of the 6 positions fully exited versus the prior quarter, the largest were ABBV ($35.85M), EXAS ($13.62M), RNAM ($11.47M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • GILD GILEAD SCIENCES INC · $35.51M
  • BMY BRISTOL-MYERS SQUIBB CO · $34.95M
  • JNJ JOHNSON & JOHNSON · $25.01M
  • EW EDWARDS LIFESCIENCES CORP · $15.95M
  • MLYS MINERALYS THERAPEUTICS INC · $12.04M
  • ACLX ARCELLX INC · $10.18M
  • DYN DYNE THERAPEUTICS INC · $10.17M
  • OCUL OCULAR THERAPEUTIX INC · $8.67M

Fully Exited (vs previous quarter)

  • ABBV ABBVIE INC · prev qtr: $35.85M
  • EXAS EXACT SCIENCES CORP COM · prev qtr: $13.62M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $11.47M
  • CDTX CIDARA THERAPEUTICS INC COM NEW · prev qtr: $5.11M
  • KYTX KYVERNA THERAPEUTICS INC · prev qtr: $3.52M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $954.55K

Insider Transactions (Form 4)

Latest Catalio Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 742,546 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,458,290 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,995,749 — SEC filing

All insider transactions →

Fund Profile

Catalio Capital Management, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 46 US equity positions with a combined value of $535.82M. HoldingsHub carries 8 quarters of its filings (Q4 2024–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121976 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $1.93B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 78%, pooled investment vehicles 13%
  • Manages 23 private funds, of which 1 hedge funds

Portfolio Structure

  • 46 positions · $535.82M reported value (Q3 2026)
  • Top 10 holdings = 48.7% of reported value
  • Largest position: AVLN (AVALYN PHARMACEUTICALS INC) at 9.0%
  • Average position size: $11.65M

Sector Tilt

  • Health Care 96.3%
  • Industrials 2.8%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q3 2026: 13 new, 13 added, 14 reduced, 6 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 94.1%
Other 5.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 289.31K $35.51M 6.28%
6.28%
New
2 647.90K $34.95M 6.18%
6.18%
New
3 360.43K $34.37M 6.07%
6.07%
Add
4 410.70K $31.41M 5.55%
5.55%
Reduce
5 25.92K $27.86M 4.92%
4.92%
Reduce
6 653.57K $26.93M 4.76%
4.76%
Reduce
7 119.27K $25.43M 4.50%
4.50%
Reduce
8 1.20M $25.14M 4.44%
4.44%
Reduce
9 120.84K $25.01M 4.42%
4.42%
New
10 29.80K $23.00M 4.07%
4.07%
Reduce
11 252.90K $17.59M 3.11%
3.11%
Reduce
12 360.34K $16.68M 2.95%
2.95%
Reduce
13 258.38K $16.42M 2.90%
2.90%
Reduce
14 187.05K $15.95M 2.82%
2.82%
New
15 27.21K $15.41M 2.72%
2.72%
Reduce
16 62.27K $14.27M 2.52%
2.52%
Reduce
17 821.20K $13.34M 2.36%
2.36%
Reduce
18 98.51K $13.29M 2.35%
2.35%
Reduce
19 257.46K $12.80M 2.26%
2.26%
Reduce
20 5.49M $12.08M 2.13%
2.13%
Add
21 331.85K $12.04M 2.13%
2.13%
New
22 699.00K $11.60M 2.05%
2.05%
Reduce
23 564.46K $10.30M 1.82%
1.82%
Reduce
24 156.11K $10.18M 1.80%
1.80%
New
25 519.72K $10.17M 1.80%
1.80%
New
26 110.43K $8.77M 1.55%
1.55%
Reduce
27 714.50K $8.67M 1.53%
1.53%
New
28 294.36K $8.21M 1.45%
1.45%
Hold
29 1.45M $7.71M 1.36%
1.36%
Reduce
30 288.35K $6.90M 1.22%
1.22%
Add
31 267.06K $6.68M 1.18%
1.18%
New
32 136.96K $5.53M 0.98%
0.98%
New
33 162.55K $3.74M 0.66%
0.66%
Reduce
34 113.86K $3.32M 0.59%
0.59%
New
35 30.31K $2.59M 0.46%
0.46%
Reduce
36 201.30K $2.28M 0.40%
0.40%
New
37 25.50K $2.09M 0.37%
0.37%
New
38 1.26M $1.90M 0.34%
0.34%
Add
39 1.32M $1.29M 0.23%
0.23%
Add
40 10.45K $1.09M 0.19%
0.19%
Reduce
41 142.98K $1.05M 0.19%
0.19%
Hold
42 528.99K $856.97K 0.15%
0.15%
Hold
43 196.86K $805.15K 0.14%
0.14%
Hold
44 118.28K $438.81K 0.08%
0.08%
Hold
45 14.72K $157.04K 0.03%
0.03%
Hold

FAQ

What did Catalio Capital Management, LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Catalio Capital Management, LP reported 45 equity positions worth $565.79M in aggregate; its largest disclosed positions were GILD ($35.51M), BMY ($34.95M), BSX ($34.37M).

How large is Catalio Capital Management, LP's portfolio?

Catalio Capital Management, LP reported $565.79M of long equity holdings across 45 positions as of 2025-Q4. Top-10 holdings account for 51.2% of reported value.

What is Catalio Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/catalio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →